Literature DB >> 14653833

Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole.

M Borjesson1, P Rolny, C Mannheimer, M Pilhall.   

Abstract

BACKGROUND: Nutcracker oesophagus is characterized by high-amplitude oesophageal contractions. Recent data have shown a high prevalence of gastro-oesophageal acid reflux in patients with nutcracker oesophagus and, in open-label trials, patients seemed to benefit from acid suppression. Therefore, it has been suggested that non-cardiac chest pain in patients with nutcracker oesophagus may be related to reflux rather than to the motor abnormality itself. AIMS: To investigate the effect of intensive acid-suppressive treatment on chest pain in patients with nutcracker oesophagus.
METHODS: Nineteen patients with nutcracker oesophagus received lansoprazole or placebo in a double-blind, randomized, cross-over study.
RESULTS: Significant reductions in pain intensity (P < 0.006) and pain duration (P < 0.05) were registered during the study. The magnitude of symptom relief achieved with lansoprazole did not differ significantly from that achieved with placebo. The motility pattern did not change during the study.
CONCLUSIONS: This study does not prove that acid-suppressive therapy is effective for pain relief in nutcracker oesophagus. As the amelioration of pain was not accompanied by any change in the nutcracker oesophagus pattern, it is unlikely that the high-amplitude oesophageal contractions are the cause of pain. Thus, the possible role of acid in the pathophysiology of pain in nutcracker oesophagus needs further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14653833     DOI: 10.1046/j.1365-2306.2003.01788.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

1.  Phenotypes and clinical context of hypercontractility in high-resolution esophageal pressure topography (EPT).

Authors:  Sabine Roman; John E Pandolfino; Joan Chen; Lubomyr Boris; Daniel Luger; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2011-09-20       Impact factor: 10.864

Review 2.  Treatment of esophageal (noncardiac) chest pain: an expert review.

Authors:  Enrique Coss-Adame; Askin Erdogan; Satish S C Rao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-28       Impact factor: 11.382

3.  A questionnaire study to assess long-term outcome in patients with abnormal esophageal manometry.

Authors:  H L Spencer; L Smith; S A Riley
Journal:  Dysphagia       Date:  2006-07       Impact factor: 3.438

4.  Hypercontractile esophagus responsive to potassium-competitive acid blockers: a case report.

Authors:  Yuyang Shao; Chen Xie; Huang Feng; Donglin Yan; Weichang Chen
Journal:  BMC Gastroenterol       Date:  2022-06-23       Impact factor: 2.847

5.  Are there any differences between nutcracker esophagus with and without reflux?

Authors:  Luiz Filipe Duarte Silva; Eponina Maria de Oliveira Lemme
Journal:  Dysphagia       Date:  2007-04-25       Impact factor: 3.438

6.  Jackhammer esophagus: Assessing the balance between prepeak and postpeak contractile integral.

Authors:  Y Xiao; D A Carlson; Z Lin; N Alhalel; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2017-11-29       Impact factor: 3.598

7.  Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors.

Authors:  Ivan Kristo; Katrin Schwameis; Svenja Maschke; Alexander Kainz; Erwin Rieder; Matthias Paireder; Gerd Jomrich; Sebastian F Schoppmann
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.